Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-UMIN000059212) titled 'Evaluation of efficiency and safety for lascufloxacin drip infusion use for atypical pneumonia,including mycoplasma ,and legionella in the Saitama western area' on Oct. 2.
Study Type: Observational
Study Design:
Not selected Not selected
Primary Sponsor: saitama medical university
Condition:
atypical pneumonia,including mycoplasma ,and legionella
Recruitment Status: Not Recruiting
Phase: Not selected
Date of First Enrollment: 2025/12/01
Target Sample Size: 50
Countries of Recruitment:
Japan
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067725
Publishe...